Spotlight on Melphalan Flufenamide: An Up-and-Coming Therapy for the Treatment of Myeloma

Despite recent therapeutic advances, multiple myeloma (MM) patients experience relapses as they become resistant to various classes and combinations of treatment. Melphalan (L-PAM) is an ageless drug. However, its use in the autologous stem cell transplantation (ASCT) setting and the innovative quad...

Descripción completa

Detalles Bibliográficos
Autores principales: Morabito, Fortunato, Tripepi, Giovanni, Martino, Enrica Antonia, Vigna, Ernesto, Mendicino, Francesco, Morabito, Lucio, Todoerti, Katia, Al-Janazreh, Hamdi, D’Arrigo, Graziella, Canale, Filippo Antonio, Cutrona, Giovanna, Neri, Antonino, Martino, Massimo, Gentile, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275138/
https://www.ncbi.nlm.nih.gov/pubmed/34262262
http://dx.doi.org/10.2147/DDDT.S295215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275138/
https://www.ncbi.nlm.nih.gov/pubmed/34262262
http://dx.doi.org/10.2147/DDDT.S295215

Ejemplares similares